Bob joined the FDA in 2003. He is currently the acting Director of the Office of Process & Facilities. Prior to the formation of OPQ, Bob was acting Associate Director for Policy Development in OPS. He was also a Division Director and CMC Team Leader in OGD. Prior to joining the FDA, Bob spent 7 years in the pharmaceutical industry with experience related to management of quality systems, method development, and support of manufacturing process development, scale-up and validation.